Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) [Phase 2]
A Phase 2 trial of HepTcell immunotherapy in patients with inactive chronic hepatitis B was terminated, and results were posted on December …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients [Phase 2]
Phase 2 clinical trial to evaluate the efficacy and safety of converting to entecavir orally disintegrating tablet in stable liver transplan…
-
EMA approval · 2025-12-03EMA Authorised: Baraclude (Entecavir) — Bristol-Myers Squibb Pharma EEIG
The European Medicines Agency authorised Baraclude (entecavir) for chronic hepatitis B. The marketing authorization holder is Bristol-Myers …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
A recruiting clinical trial evaluating the combined use of Bacteroides fragilis and branched-chain amino acids on HBsAg clearance in patient…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Strengthening Hepatitis B Screening, Linkage to Care and Long-Term Monitoring in Phichit Province, Thailand: A Birth Bohort Approach [Phase 4]
A Phase 4 clinical trial update from Thailand aims to strengthen hepatitis B screening, linkage to care, and long-term monitoring in Phichit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma [NA]
This clinical trial protocol compares tenofovir alafenamide (TAF) monotherapy to entecavir (ETV) plus TAF for hepatitis B-related hepatocell…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection [Phase 1, Phase 2]
A platform Phase 1/2 study evaluating investigational therapies for chronic hepatitis B infection has completed, with results posted on Nove…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB). [Phase 2]
This update relates to a Phase 2 clinical trial evaluating the efficacy and safety of AHB-137 Injection in adults with chronic hepatitis B; …
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs [Phase 2]
A multicenter Phase 2 clinical trial evaluating AHB-137 injection in combination with other Hepatitis B therapies for chronic hepatitis B is…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: National Liver Cancer Screening Trial [Phase 4]
Phase 4 liver cancer screening trial is currently recruiting, sponsored by the University of Texas Southwestern Medical Center.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection [Phase 2]
A Phase 2 clinical trial evaluating TQ-A3334 in combination with nucleoside analogs as initial therapy for chronic hepatitis B is ongoing. T…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients [NA]
This completed clinical trial investigates whether adding pegylated interferon alfa-2a can promote HBsAg loss in patients with chronic hepat…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection [Phase 2]
Phase 2 clinical trial update for HT-101 and HT-102 in Chronic Hepatitis B showing status as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of ALG-000184 after single and multiple doses in health…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hepatitis B and C Within the Chinese Community in Milan
A clinical trial investigating Hepatitis B and Hepatitis C in the Chinese community in Milan is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Comparison of a Handheld Elastography Device With iLivTouch in Chronic Liver Disease Patients
This clinical trial update describes a study comparing a handheld elastography device with iLivTouch in chronic liver disease patients, incl…
-
EMA approval · 2025-11-18EMA Authorised: Viread (tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC
The European Medicines Agency authorised Viread (tenofovir disoproxil fumarate) for chronic hepatitis B and HIV infections; the marketing au…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B [Phase 2]
A Phase 2 multicenter randomized trial evaluating HRS-5635 injection alone or with other agents for chronic hepatitis B; the study is curren…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT. [NA]
Clinical trial update on the effectiveness and safety of TMF for chronic hepatitis B patients with normal ALT; the study is currently active…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors [Phase 4]
Phase 4 clinical trial evaluating light-assisted ex vivo treatment and antiviral strategies for recipients of lungs from HBV-infected donors…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B [Phase 4]
A Phase 4 prospective cohort trial is evaluating PEG-IFN-α-2b to improve clinical cure rates in pediatric patients with chronic hepatitis B;…
-
EMA approval · 2025-11-07EMA Authorised: HBVaxPro (hepatitis B, recombinant surface antigen) — Merck Sharp & Dohme B.V.
EMA authorised HBVaxPro, a recombinant hepatitis B surface antigen vaccine, for immunization against hepatitis B in the European Union. The …
-
EMA approval · 2025-11-05EMA Authorised: Pegasys (peginterferon alfa-2a) — pharmaand GmbH
EMA authorised Pegasys (peginterferon alfa-2a) for chronic hepatitis C, chronic hepatitis B, polycythemia vera, and essential thrombocythemi…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection [Phase 2]
Open-label Phase 2 study of AB-729 with pegylated interferon alfa-2a for chronic hepatitis B has completed.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B [Phase 1]
A Phase 1 clinical trial evaluating a Toll-like receptor 9 adjuvanted vaccine for chronic hepatitis B. The study is currently recruiting and…